Cryoablation for Monomorphic Ventricular Tachycardia (VTS)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT07650032

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07650032
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07650032. Allocation not applicable; no masking; primary purpose treatment. Start 2026-08-01 (actual); primary completion 2027-03-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cryoablation for Monomorphic Ventricular Tachycardia (VTS)
Acronym
FULCRUM-VT
Condition
Ventricular Tachycardia, Sustained
Condition
Ventricular Tachycardia, Monomorphic
Intervention (Device)
Ultra Low Temperature Ablation (ULTA)
Lead sponsor
Adagio Medical (class: industry)

Record details

Record id
cardio:ct-nct07650032
Content hash
8c3338b7395e703bb466e86e22b0981e05d4decaf414aad4f1a85e21347ac60d